Internal Medicine · Brooklyn, NY
NPI
1720016793
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2705 Mermaid Ave
Brooklyn, NY, 11224
Phone (718) 265-2222
Groups this clinician bills Medicare through
Medicare paid, 2024
$605K
10,549 services
Medicare patients, 2024
488
Average age 80
Drug cost, 2024
$4.5M
29,341 prescriptions
Company payments, 2025
$2,556
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael Tavdy was code 99491 (chronic, principal, and transitional care management), 1,663 times for 225 patients. In total Michael Tavdy billed 10,549 services in 125 codes, and Medicare paid $605K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99491 Chronic, Principal, and Transitional Care Management | Office | 1,663 | 225 | $73.95 | $123K |
| 99213 Office E&M - Established | Office | 1,159 | 350 | $73.38 | $85K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 824 | 109 | $0.79 | $649 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 499 | 149 | $0.96 | $481 |
| 99233 Hospital E&M - Subsequent | Facility | 443 | 88 | $103.24 | $46K |
| 99214 Office E&M - Established | Office | 369 | 226 | $105.60 | $39K |
| 96365 Intravenous Infusion, Hydration | Office | 369 | 105 | $56.09 | $21K |
| G0447 Face-to-face behavioral counseling for obesity, 15 minutes | Office | 366 | 130 | $27.71 | $10K |
| 96372 Injection Administration | Office | 330 | 129 | $11.95 | $3,944 |
| J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) | Office | 298 | 83 | $1.01 | $300 |
| 99497 Care Management/Coordination | Office | 289 | 285 | $85.53 | $25K |
| J3475 Injection, magnesium sulfate, per 500 mg | Office | 275 | 78 | $0.44 | $120 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 250 | 250 | $143.84 | $36K |
| G0008 Administration of influenza virus vaccine | Office | 228 | 219 | $37.09 | $8,457 |
| 90662 Vaccine Product | Office | 198 | 198 | $81.82 | $16K |
By year: 2022 $641K for 11,487 services; 2023 $623K for 10,627 services; 2024 $605K for 10,549 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87811 Immunoassay | 112 | 83 | $40.55 | $4,542 |
| 87804 Immunoassay | 107 | 49 | $16.22 | $1,736 |
| 36415 Venipuncture Blood Collection | 106 | 89 | $8.65 | $917 |
| 82962 Clinical Chemistry | 50 | 25 | $3.21 | $161 |
| 87880 Immunoassay | 16 | 13 | $16.20 | $259 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael Tavdy prescribed most often to Medicare patients was Amlodipine Besylate, with 1,143 prescriptions and refills. In total Michael Tavdy wrote 29,341 Medicare prescriptions that cost $4.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 1,143 | 1,221 | 153 | $4,466 |
| Atorvastatin Calcium Generic | 979 | 1,102 | 141 | $6,194 |
| Synthroid Levothyroxine Sodium | 905 | 943 | 105 | $41K |
| Rosuvastatin Calcium Generic | 815 | 841 | 104 | $18K |
| Diclofenac Sodium Generic | 751 | 758 | 119 | $267K |
| Vascepa Icosapent Ethyl | 611 | 623 | 86 | $219K |
| Gabapentin Generic | 595 | 614 | 89 | $4,715 |
| Metoprolol Succinate Generic | 574 | 622 | 73 | $7,090 |
| Memantine Hcl Generic | 565 | 589 | 79 | $18K |
| Tamsulosin Hcl Generic | 553 | 579 | 72 | $7,229 |
| Omeprazole Generic | 537 | 558 | 80 | $3,828 |
| Clopidogrel Clopidogrel Bisulfate | 446 | 474 | 49 | $3,490 |
| Linzess Linaclotide | 425 | 425 | 57 | $224K |
| Olmesartan Medoxomil Generic | 421 | 430 | 72 | $11K |
| Metoprolol Tartrate Generic | 420 | 453 | 60 | $1,742 |
Brand drugs: 7,679 claims; generic drugs: 21,132 claims; opioid claims: 429.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael Tavdy $2,556 ($2,556 in general payments such as food, travel and fees) from 25 companies. The largest payer was Abbvie Inc. with $277.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 15 | $277 |
| Axsome Therapeutics, Inc. AXSM | 13 | $244 |
| Astellas Pharma US Inc 4503.T | 6 | $223 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 7 | $190 |
| Viatris Specialty LLC | 12 | $171 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $167 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 9 | $154 |
| Amgen Inc. AMGN | 10 | $152 |
| Sumitomo Pharma America, Inc. 4506.T | 9 | $139 |
| Biogen, Inc. BIIB | 5 | $128 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.